Comment on the risk of hepatocellular carcinoma with chronic hepatitis B infection in Sweden
Satender Pal Singh, Nitisha Mondia – 9 July 2022
Loss of SLC46A1 decreases tumor iron content in hepatocellular carcinoma
Dongyao Wang, Huiwen Wu, Jianxin Yang, Min Li, Changquan Ling, Zelong Gao, Hongtao Lu, Hui Shen, Yuxiao Tang – 9 July 2022 – It is interesting that high iron is an independent inducer or cofactor of hepatocellular carcinoma (HCC) while the amount of iron is decreased in the liver tumor tissues. Due to the previous findings that iron deficiency promoted HCC metastasis, it is of significance to identify the underlying mechanism of iron deficiency in HCC. The tumor iron content and expressions of iron‐metabolic molecules were observed in the primary liver cancers of rats and mice.
Sociodemographic and georaphic differences in the US epidemiology of autoimmune hepatitis with and without cirrhosis
Therese Bittermann, James D. Lewis, Cynthia Levy, David S. Goldberg – 9 July 2022
Reply
Hong Zhu, Bo Yang – 9 July 2022
The limited function of most circRNAs as a microRNA sponge
Ye‐Zhao Wang – 9 July 2022
Reply to: The limited function of most circRNAs as a microRNA sponge
Hui Li, Chang Liu, Hong Wu – 9 July 2022
Alpha‐fetoprotein slope over 7.5 ng/ml over 3 months before liver transplantation for hepatocellular carcinoma predicts recurrence even after controlling for alpha‐fetoprotein at liver transplantation
Jeanne‐Marie Giard, Jennifer L. Dodge, Francis Y. Yao, Neil Mehta – 8 July 2022
Reply
Vladimir Loukachov, Karel Dort, Robin Erken, Henk W. Reesink, Neeltje Kootstra – 8 July 2022
Machine learning models are superior to noninvasive tests in identifying clinically significant stages of NAFLD and NAFLD‐related cirrhosis
Devon Chang, Emily Truong, Edward A. Mena, Fabiana Pacheco, Micaela Wong, Maha Guindi, Tsuyoshi T. Todo, Nabil Noureddin, Walid Ayoub, Ju Dong Yang, Irene K. Kim, Anita Kohli, Naim Alkhouri, Stephen Harrison, Mazen Noureddin – 8 July 2022